Bristol Myers Squibb to acquire Mirati Therapeutics in $4.8bn deal

Pallavi Madhiraju- October 9, 2023 0

Bristol Myers Squibb (NYSE: BMY) is set to acquire Mirati Therapeutics, Inc. (NASDAQ: MRTX) at $58.00 per share in a cash deal valued at $4.8 ... Read More

BMS to acquire precision oncology company Turning Point Therapeutics for $4.1bn

pallavi123- June 14, 2022 0

Bristol Myers Squibb (BMS) has agreed to acquire Turning Point Therapeutics, a clinical-stage precision oncology company based in California, for $4.1 billion. Listed on the ... Read More

Bristol Myers Squibb completes $13.1bn acquisition of MyoKardia: A strategic move to strengthen cardiovascular portfolio

pharmanewsdaily- November 18, 2020 0

Bristol Myers Squibb has successfully completed its acquisition of MyoKardia, a clinical-stage biopharmaceutical company based in California. The $13.1 billion deal, announced in October 2020, ... Read More

Bristol Myers Squibb to acquire MyoKardia for $13.1bn: A strategic move to strengthen cardiovascular portfolio

pharmanewsdaily- October 5, 2020 0

Bristol Myers Squibb (BMS), a leading global biopharmaceutical company, has announced an agreement to acquire MyoKardia, a California-based clinical-stage biotechnology company, for $13.1 billion. This ... Read More

Bristol-Myers Squibb wraps up $74bn acquisition of Celgene

pharmanewsdaily- November 22, 2019 0

Bristol-Myers Squibb has wrapped up its $74 billion acquisition of Celgene having got regulatory approval from all government authorities necessary for closing the merger agreement ... Read More

FTC clears decks for Bristol-Myers Squibb acquisition of Celgene

pharmanewsdaily- November 17, 2019 0

Bristol-Myers Squibb acquisition of Celgene : US pharma giant Bristol-Myers Squibb said that the US Federal Trade Commission (FTC) has given its clearance for its ... Read More

Bristol-Myers Squibb to acquire Celgene in $74bn pharma megadeal

pharmanewsdaily- January 6, 2019 0

Bristol-Myers Squibb has reached a definitive agreement to acquire Celgene Corporation in a monumental cash-and-stock deal worth approximately $74 billion. This acquisition will merge two ... Read More